NAC1 immunoreactivity intensity of OED and CIS/OSCC samples.

<p>NAC1 immunoreactivity intensity of OED and CIS/OSCC samples.</p

Association between pathological classification and patient characteristics and NAC1 expression.

<p>Association between pathological classification and patient characteristics and NAC1 expression.</p

NAC1 labeling index of OED and CIS/OSCC samples.

<p>NAC1 labeling index of OED and CIS/OSCC samples.</p

Nucleus accumbens-associated protein 1 (NAC1) expression.

<p>Nucleus accumbens-associated protein 1 (NAC1) expression.</p

Multivariate regression analysis of OED and CIS/OSCC classification.

<p>NAC1: nucleus accumbens-associated protein 1, OED: oral epithelial dysplasia, CIS: carcinoma in situ, OSCC: oral squamous cell carcinoma, LI: labeling index, IRI: immunoreactive intensity, CI: confidence interval.</p><p>Multivariate regression analysis of OED and CIS/OSCC classification.</p

Univariate regression analysis of OED and CIS/OSCC classification.

<p>NAC1: nucleus accumbens-associated protein 1, LI: labeling index, IRI: immunoreactive activity, OED: oral epithelial dysplasia, CIS: carcinoma in situ, OSCC: oral squamous cell carcinoma, CI: confidence interval.</p><p>Univariate regression analysis of OED and CIS/OSCC classification.</p

Morphometry of pathologic nodal status, pN(+) and pN(−), in all cases of OSCC.

<p>Morphometry of pathologic nodal status, pN(+) and pN(−), in all cases of OSCC.</p

Illustration of each level of the cervical lymph node.

<p>Illustration of each level of the cervical lymph node.</p

Illustration and formulas of parameters for quantitative estimation of nuclear parameters.

<p>NACV: nuclear area coefficient of variation.</p

Pathologic nodal classification and number and level of metastatic lymph nodes.

<p>Pathologic nodal classification and number and level of metastatic lymph nodes.</p